The Institutes for Pharmaceutical Discovery

Gordon P. Polley is Founder and Chairman of the Institutes for Pharmaceutical Discovery, L.L.C. (IPD). IPD is the parent company to the Institutes for Diabetes Discovery, L.L.C. (IDD) and the Institutes for Bioanalytics, L.L.C. (IBA). More than half of Mr. Polley's 40-year professional career has been dedicated to venture initiation, financing and the management of cutting-edge biomedical organizations.

Prior to this venture, Mr. Polley was a founder and Chief Executive Officer of Molecular Diagnostics, Inc. and Molecular Therapeutics, Inc., both majority-owned affiliates of Bayer AG and Miles, Inc. During his tenure, he led these biotechnology research groups to become the nucleus of the Bayer Research Center in West Haven, Connecticut. Principal research was centered on molecular biology and related disciplines directed toward diagnosis and treatment of cancer, diabetes, infectious diseased and human genetic disorders.

Mr. Polley holds a Bachelor of Science degree from Cornell University and a graduate business degree from Harvard University.